ABRAMS.wiki는 다음과 관련된 실제 배송, 위치, 경쟁업체, 구매자, 고객, 공급업체, 공급망, 제품, 제품 포트폴리오, 연락처, 직원, 매출 정보를 제공합니다:

ABRAMS world trade wiki는 UN Comtrade (유엔 데이터베이스)와 OECD (경제협력개발기구)의 파트너로서, 지능형 알고리즘과 인공지능(AI)을 활용하여 수십억 개의 통계 데이터뿐만 아니라 화물 및 관세 데이터를 분석하고 이를 바탕으로 "독특한 비즈니스 인텔리전스 포털"을 개발했습니다 (인용: UN Comtrade / 참조).

이 페이지에서는 저희 연구팀이 개별적으로 준비한 Glenmark Pharmaceuticals Ltd.의 시장 활동에 대한 통찰을 얻을 수 있습니다.

경쟁업체, 공급업체 또는 고객의 최신 배송 내역을 무료로 확인해 보세요!

주요 경쟁업체의 최신 배송을 분석하여 공급업체, 고객 및 제품에 대한 정보를 얻으세요, 또는 다른 회사 를 선택하세요.

다단계 공급망 투명성

ABRAMS world trade wiki 는 1차 공급업체(Tier-1)의 직접적인 공급업체와 구매자만을 보여주는 것이 아닙니다. 저희 도구인 Supply Chain Intelligence 는 Tier-1 이상의 가시성 장벽을 허물어, 전체 공급망 네트워크 에 대한 포괄적인 통찰을 제공하며, 다단계 투명성 을 단 한 번의 클릭으로 제공합니다.

Supply Chain Intelligence - Export and Import

Glenmark Pharmaceuticals Ltd.의 구매 부서의 담당자는 누구인가요?

ABRAMS world trade wiki는 Glenmark Pharmaceuticals Ltd.의 구매 부서에서 현재 담당자를 찾을 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

연락 담당자는 누구인가요판매부서Glenmark Pharmaceuticals Ltd.

ABRAMS world trade wiki는 Glenmark Pharmaceuticals Ltd.의 영업 부서에서 현재 담당자를 찾을 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

다음에 대한 정보는 어디에서 찾을 수 있나요규정 준수에 Glenmark Pharmaceuticals Ltd. ?

ABRAMS world trade wiki는 전 세계에서 Glenmark Pharmaceuticals Ltd.에 대한 최신 컴플라이언스 뉴스를 검색할 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

Glenmark Pharmaceuticals Ltd.에 대한 최신 보도자료는 무엇인가요?

ABRAMS world trade wiki는 전 세계에서 Glenmark Pharmaceuticals Ltd.에 대한 최신 보도자료를 검색할 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

Glenmark Pharmaceuticals Ltd.의 공급업체는 누구인가요?: 회사의 성과는 공급업체에 크게 의존합니다. 따라서 신뢰할 수 있는 파트너 네트워크(공급업체, 딜러 및 제조업체)는 기본 요소입니다. 선하증권에서 __Glenmark Pharmaceuticals Ltd.__의 3개의 국제 공급업체 가 확인되었으며, 이들이 회사가 의존하고 있는 업체들입니다. 예를 들어, 1건의 상품 배송 을 제공한 Glenmark Pharmaceuticals Ltd. 회사를 들 수 있습니다.

2 내에서 발견된 공급업체 국가 중 제품 구매의 주요 공급처는 인도 입니다. 해당 지역에서 2 개의 상품 발송이 확인되었습니다.

Glenmark Pharmaceuticals Ltd.의 국제 조달 과 3개의 공급업체 에 대한 개요를 Company Transparency를 통해 확인하세요.
Glenmark Pharmaceuticals Ltd.의 공급망은 어떻게 구성되어 있나요?: 일반적으로 Glenmark Pharmaceuticals Ltd. 의 공급망 또는 공급 네트워크는 두 가지 관점에서 구분할 수 있습니다:

공급자 측면 (Tier-1 공급자는 직접 공급자, Tier-2는 Tier-1 공급자의 공급자, Tier-n은 Glenmark Pharmaceuticals Ltd. 공급 네트워크의 모든 레벨에서 공급자입니다).

구매자 측면 (Tier-1 구매자는 직접 구매자, Tier-2는 Tier-1 구매자의 구매자, Tier-n은 Glenmark Pharmaceuticals Ltd. 유통 네트워크의 모든 레벨에서 구매자입니다).

비즈니스의 안정성과 연속성을 보장하기 위해 공급망이나 공급 네트워크는 외부 영향이 Glenmark Pharmaceuticals Ltd. 에 가할 수 있는 피해를 최소화하도록 구성되어야 합니다. 이것은 조달 분야(공급자의 손실은 대체 공급자가 보완해야 함)와 판매 분야(구매자의 손실은 대체 구매자가 보완해야 함) 모두에 적용됩니다.

일반적으로 리스크는 상품의 비가용성, 생산의 축소 또는 중단, 비즈니스 파트너의 손실 가능성, 또는 준수 규칙 위반(예: 환경 보호, 노동법)으로 인해 공급 네트워크에서 제외되는 것으로 간주될 수 있습니다.

이 리스크는 반드시 직접적인 비즈니스 파트너(Tier 1)에만 국한되지 않으며, 충분한 대체 공급자와 구매자가 마련되지 않은 경우 전체 공급망에 영향을 미칠 수 있습니다.

Get an overview of the international supply chain of Glenmark Pharmaceuticals Ltd. (upstream/procurement and downstream/sales) from Tier-1 to Tier-n

E.G.: Tier 1 supplier Glenmark Pharmaceuticals Ltd.Tier-1 Buyer Glenmark Pharmaceuticals Inc., USA

ABRAMS world trade wiki는 첫 번째 계층(Tier-1)의 직접 공급자와 고객뿐만 아니라, Supply Chain Intelligence 도구에서 한 번의 클릭으로 여러 계층(Tier-n)에 걸친 공급 네트워크에 대한 포괄적인 인사이트를 제공합니다.
Is the supply chain of Glenmark Pharmaceuticals Ltd. stable?: Each tier in the supply chain or supply network on the supplier side of Glenmark Pharmaceuticals Ltd. involves a single risk. The more tiers, the more difficult it is to analyze and monitor the business partners. Suppliers of suppliers are generally unknown, so there is already an increasing risk at the second (Tier 2) level.

If e.g. a first Tier supplier is not adding any value, the supply chain can be shortened and the risk of failure can be minimized by skipping this supplier. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:

Analyze the potential of shortening and therefore stabilizing the supply chain of Glenmark Pharmaceuticals Ltd.
Which products does Glenmark Pharmaceuticals Ltd. purchase?: 국제 선하증권(Bill of Lading / Bills of Lading / BOL) 분석을 통해 HS 코드(HTS 코드 또는 관세율 번호)를 사용하여 __1 제품 카테고리__를 식별할 수 있으며, 이는 __Glenmark Pharmaceuticals Ltd.__이 구매한 것입니다.

이는 HS 코드 300490 로 분류되며, 다음 제품을 포함합니다:

„Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins or derivatives thereof used as vitamins)". 이 HS 코드는 총 2 번 확인되었습니다.

Get an overview of internationally purchased products by Glenmark Pharmaceuticals Ltd. with Company Transparency
Is Glenmark Pharmaceuticals Ltd. able to reduce costs in the upstream supply chain?: Each tier in the supply chain or supply network of Glenmark Pharmaceuticals Ltd. is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.

If e.g. a Tier-1 supplier from Glenmark Pharmaceuticals Ltd. that primarily trades a product and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain and reduce purchasing costs. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:

Analyze the potential of shortening the supply chain of Glenmark Pharmaceuticals Ltd. and saving costs on the procurement side.

Who are the buyers of Glenmark Pharmaceuticals Ltd.?: 기업의 성공은 근본적으로 고객에 달려 있습니다. 따라서 가능한 한 많은 안정적인 고객층을 확보하는 것이 핵심입니다. 운송장에서는 __27 국제 고객__이 Glenmark Pharmaceuticals Ltd. 으로 식별되었습니다. 예를 들어, Glenmark Pharmaceuticals Inc., USA사는 18 상품 발송 를 수령했습니다.

3 에서 발견된 고객 국가 중 제품 판매를 위한 주요 대상국은 미국 입니다. 해당 기간 동안 2,787 건의 상품 배송 이 이루어졌습니다.

Glenmark Pharmaceuticals Ltd. 의 국제 영업 및 27 명의 고객 에 대한 개요를 확인하세요. 자세한 내용은 Company Transparency에서 확인하실 수 있습니다.
Which products does Glenmark Pharmaceuticals Ltd. sell?: 국제 선하증권(Bill of Lading / Bills of Lading / BOL) 분석을 통해 11 개의 다양한 제품 카테고리 가 확인되었으며, 이는 Glenmark Pharmaceuticals Ltd. 이 판매한 것입니다.

이들은 HS 코드(HTS 코드 또는 관세율 번호)를 통해 구분할 수 있습니다.

예를 들어, HS-Code 300490 는 다음과 같은 제품을 분류합니다:

„Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins or derivatives thereof used as vitamins)". 이 HS 코드는 총 752회 확인되었습니다.

From the product descriptions of the analyzed bills of lading (bill of lading/ bills of lading/ BOL), the following products sold to various buyers can be identified as an example:

8 PALLETS 408 CARTONS PHAR MACEUTICALS AS UNDER GABAP ENTIN TAB 800MG 500 NDC CODE :68462012705 FDA PRODUCT CODE NO 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTI N TAB 800MG 500 NDC CODE:6846 2012705 FDA PRODUCT CODE NO 61 N C A 69 H. T. S NO.: 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F2245200016 8 DT. 15.04.2023 F22452000174 DT. 15.04.2023 S/BILL NO: 93 55873 DT 17-APR-2023 S/BILL NO:9355898 DT 17-APR-2023 NET WT.2924.67 KGS 01 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHW AH 07430 USA

8 PALLETS 405 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FDA PRODUCT CODE NO 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE: -ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F 22452000251 DT. 19.04.2023 NET WT.2926.26 KGS 01 DATA LOGGERS S/BILL NO: 9430365 DT 0-APR-2023 NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH 07430 USA

PHARMACEUTICALS AS UNDER ACF ADAPALENE GEL 0.1 45GM AMAZON SUS010005P25060191 COMMERCIAL CUSTOM INVOICE NO. F22352002920 DT. 30.09.2022 NET.WT. 714.44 KGS. SB.NO 5160174 DT 31.10.2022 FREIGHT COLLECT

21 PALLETS 1095 CARTONS PHA RMACEUTICALS AS UNDER GABAP ENTIN TAB 600MG 500 NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTIN TAB 800MG 500 NDC CODE:684620 12705 FDA PRODUCT CODE NO 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352003941 DT. 27.11.2022 NET WT:7445.75 KGS 00 DATA LOGGERS SET TEMPERATURE +18 DEGREES CONTAINER NO. MNBU0 252768 SBILL NO: 576196 6 DT: 28.11.2022 NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH 07430 USA

11 PALLETS 954 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTI N TAB 600MG 100 NDC CODE:6846 2012601 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F2235200335 9 DT. 26.10.2022 F22352003362 DT. 26.10.2022 S/BILL NO: 50 62846 DT 26-OCT-2022 S/BILL NO: 5062862 DT 26-OCT-2022 01 DATA LOGGERS NET WT. 3349. 01 KGS SET TEMPERATURE +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 50, CORPORATE DRIVE, NEW JERSEY MAHWAH 07430 USA

39 PALLETS 1711 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 800MG 100 NDC CODE:68462012701 FDA PRODUCT CODE NO 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT NORETHINDRONE TAB 0.35MG 84 NDC CODE :68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO .: 3006.60.00.00 ANDA NO.:91 -209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO. : 3004.39.00.50 ANDA NO.:-91 -090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETRIOSIS AND ABNORMAL UTERINE BLEEDING NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANALGESIC VERAPAMIL HCL ER TAB 240MG 100 NDC CODE:6846202600 1 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90 .92.20 ANDA NO.:-78-906 THER APEUTICE USE:-ANGINA CLOTR IMAZOLE CREAM 1% 45GM NDC CODE:68462018147 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 0-219 THERAPEUTICE USE: TREATMENT OF CANDIDIASIS COMMERCIAL & CUSTOM INVOICE NO. F22 352003082 DT. 10.10.2022 F223 52003088 DT. 10.10.2022 F2235 2003091 DT. 10.10.2022 F22352 003092 DT. 10.10.2022 S/BILL NO: 4742169 DT 11-OCT-2022 S/ BILL NO: 4743779 DT 11-OCT-202 2 S/BILL NO: 4742349 DT 11-OC T-2022 S/BILL NO: 4742339 DT 11-OCT-2022 NET WT. 7391.85 K GS 02 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE +18 DEGREES TEMPERATURE RANGE +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH 07430 USA

14 PALLETS 700 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H . T. S NO.: 3006.60.00.00 AN DA NO.: 204847 THERAPEUTICE USE: CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F2235200301 5 DT. 06.10.2022 S/BILL NO: 655013 DT 06-OCT-2022 NET WT. 1,579.20 KGS NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH 07430 USA

5 PALLETS 269 CARTONS PHA RMACEUTICALS AS UNDER GABAP ENTIN TAB 600MG 500 NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F2235200 2753 DT. 23.09.2022 S/BILL NO : 4411195 DT:24/09/2022 NET WT. 1,486.14 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE +18 DEGREES TEMPERATURE RANGE +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWA H 07430 USA

31 PALLETS 2381 CARTONS PHARMACEUTICALS AS UNDER BRIELLYN TAB 0.4/0.035MG 84 N DC CODE:68462031629 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.: 90-538 THERAPEUTICE USE : ORAL CONTRACEPTIVE NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:- 91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETRIO S IS AND ABNORMAL UTERINE BLEEDING TOPIRAMATE TAB 100MG 500 NDC CODE:68462010905 FD A PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.: 77627 THERAPEUTI CE USE: :#ANTICONVULSANT T ELMISARTAN TAB 20MG 30 NDC CODE:68462019930 FDA PRODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 090032 THERAPEUTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE TELMISARTAN TAB 80 MG 30 NDC CODE:68462020130 H TS NO 3004.90.92.20 FDA CODE 62 O C A 09 ANDA NO.: 900 32 THERAPEUTICE USE INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE VERAPAMIL HCL ER TAB 180MG 500 NDC CODE:6846202930 5 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90 .92.20 ANDA NO.: 90-700 THER APEUTICE USE: ANGINA HAI LEY 24 FE TAB 1MG/20MCG-75MG 4 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22352002 972 DT. 30.09.2022 F223520030 05 DT. 04.10.2022 F2235200300 8 DT. 04.10.2022 F22352003020 DT. 06.10.2022 S/BILL NO: 46 54988 DT 06-OCT-2022 S/BILL NO: 4650195 DT 06-OCT-2022 S/BILL NO: 4650221 DT 06-OCT-2022 S/BILL NO: 4655011 DT 06-OCT -2022 NET WT. 5,335.55 KGS DATA LOGGERS SET TEMPERATURE +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH 07430 USA

1 X 40 HC REEFER CONTAINER STC 19 PACKAGES ONLY NINETEEEN PACKAGES ONLY TOTAL 1900 CARTONS REPACKED ON 19 PALLETS ONLY PHARMACEUTICALS AS UNDER ACF ADAPALENE GEL 0.1 15GM AMAZON NDC CODE SUS010005P25060112 ACF ADAPALENE GEL 0.1 45GM AMAZON NDC CODE SUS010005P25060191 ACF ADAPALENE GEL 0.1 45GM AMAZON NDC CODE SUS010005P25060191 ACF ADAPALENE GEL 0.1 15GM AMBI NDC CODE

Get an overview of internationally sold products by Glenmark Pharmaceuticals Ltd. with Company Transparency
Is Glenmark Pharmaceuticals Ltd. able to optimize its profits on the buyer side of the supply chain? (downstream): Each tier in the buyer side of the supply chain or supply network of Glenmark Pharmaceuticals Ltd. is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.

If e.g. a Tier-1 buyer from Glenmark Pharmaceuticals Ltd. that primarily trades products and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain downstream giving a potential to optimize profit margins for Glenmark Pharmaceuticals Ltd.. A previous Tier-2 buyer now turns into a Tier-1 buyer, which we call "go-direct". In our tool Supply chain Intelligence as far as international buyers are concerned, this analysis can be done with one click:

Analyze the potential to shorten the supply chain and optimize the profit margins on the sales side of Glenmark Pharmaceuticals Ltd.

Is Glenmark Pharmaceuticals Ltd. a reliable supplier?: Each company contributes significantly minimizing risks for its buyers, through its own stability. Internal risks (endogenous factors) can be e.g. financially (financial ratios, free cash flow, balance sheets) or operationally (production, lead times). Since 2021, external risks have increased due to worldwide shortages and are an important factor as to whether a supplier such as Glenmark Pharmaceuticals Ltd. can itself reliably deliver due to external dependencies (exogenous factors).

To assess this, data analysis should be conducted to get practical answers:

How is the supply chain or supply network structured on the supplier side of Glenmark Pharmaceuticals Ltd.? Are there suppliers or products in the supply chain that are reported as critical, e.g. in international media?

Which buyers does Glenmark Pharmaceuticals Ltd. consistently sell to over a long period of time that can be identified as a good reference?
Does Glenmark Pharmaceuticals Ltd. have problems supplying at the moment?: The more constant outgoing shipments of a company’s, the easier it is to assess potential problems for a supplier like Glenmark Pharmaceuticals Ltd.

Operational aspects like a stable supply chain, an in-house production and reliable logistics define sustainable performance.

Since 2021, global supply shortages have increasingly added external factors as to whether a supplier like Glenmark Pharmaceuticals Ltd. can deliver reliably itself through dependencies.

Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) the current supply and performance capacity can be indirectly analyzed.

Here you can see an analysis of shipments by Glenmark Pharmaceuticals Ltd. to international buyers in the last few months with Company Transparency
Does Glenmark Pharmaceuticals Ltd. have procurement problems at the moment?: The more constant incoming shipments, the better one can determine possible procurement problems of a company like Glenmark Pharmaceuticals Ltd.

Since 2021, there are increasingly external factors due to global supply shortages, whether a company, no matter manufacturer or distributor, can reliably deliver through dependencies.

Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) it is possible to analyze current procurement stability and thus ultimately also to derive an indication of the company’s delivery and performance capability.

Here you can see an analysis of shipments from international suppliers to Glenmark Pharmaceuticals Ltd. in the last few months with Company Transparency

What is the CO₂ footprint and sustainability of Glenmark Pharmaceuticals Ltd. products?: Sourcing products as regionally as possible with short shipping routes and the use of sustainable materials define the CO₂ footprint and sustainability of the products of any company, including Glenmark Pharmaceuticals Ltd.

After many companies, predominantly due to cost savings, have been building their networks increasingly internationally for years, there is now an increasing trend of so-called “on-shoring” or “near-shoring”. Attempting to include suppliers who are the closest to the supply chain because of financial, risk, environmental and image aspects:

Saving international freight costs, which have risen extremely since 2021.

Minimizing risks caused by logistics problems (e.g. the Suez Canal obstruction in 2021)

Attempting to reduce the carbon footprint when purchasing products.

Setting and meeting sustainability goals for own products of Glenmark Pharmaceuticals Ltd.

Based on the development of current shipments (in terms of number of shipments and quantity of goods) and changes in international suppliers and routes, it is possible to analyze the extent to which Glenmark Pharmaceuticals Ltd. has already made efforts in recent months and years, to focus on environmentally relevant aspects, like carbon footprint and sustainability in its business activities.

Get an overview of the international shipments that have an impact on the CO₂ footprint, as well as the sustainability of Glenmark Pharmaceuticals Ltd.

Who are the competitors of Glenmark Pharmaceuticals Ltd.?: Generally you can differentiate the competition of Glenmark Pharmaceuticals Ltd. by the purchase and sales perspective.

Start the competitive analysis on the purchase side.

Start the competitive analysis on the sales side.
Who are the competitors of Glenmark Pharmaceuticals Ltd. on the purchase side?: Competitors of Glenmark Pharmaceuticals Ltd. on the purchase side (procurement of raw materials and components for production or distribution) are exposed on ABRAMs wiki under Competitive Intelligence, purchased products, classified by HS-Codes (e.g. 300490) or by top product terms.
Who are the competitors of Glenmark Pharmaceuticals Ltd. on the sales side (selling similar products)?: Competitors on the sales side of Glenmark Pharmaceuticals Ltd. (selling raw materials or components for production or distribution) are exposed on ABRAMS wiki under Competitive Intelligence, sold products classified by HS-Codes (e.g. 300490, 300660) or by top product terms.